Ssnd Medimart Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 11-07-2024
- Paid Up Capital ₹ 1.11 Cr
as on 11-07-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.00 Cr
as on 11-07-2024
- Revenue -62.75%
(FY 2022)
- Profit -1826.19%
(FY 2022)
- Ebitda 456.07%
(FY 2022)
- Net Worth -84.65%
(FY 2022)
- Total Assets -80.65%
(FY 2022)
About Ssnd Medimart
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.11 Cr.
The company has closed loans amounting to ₹4.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Abhilasha Sharma, Sandeep Sharma, and Pramod Sharma serve as directors at the Company.
- CIN/LLPIN
U24100DL2017PTC316190
- Company No.
316190
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ssnd Medimart?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhilasha Sharma  | Director | 01-Aug-2020 | Current |
| Sandeep Sharma | Director | 17-Apr-2017 | Current |
| Pramod Sharma | Director | 25-Jun-2018 | Current |
Financial Performance and Corporate Structure Insights of Ssnd Medimart.
Ssnd Medimart Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 62.75% decrease. The company also saw a substantial fall in profitability, with a 1826.19% decrease in profit. The company's net worth observed a substantial decline by a decrease of 84.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ssnd Medimart?
In 2020, Ssnd Medimart had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Jan 2019 | ₹2.00 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 19 Jun 2017 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Ssnd Medimart?
Ssnd Medimart has a workforce of 28 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ssnd Medimart, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ssnd Medimart's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
